litlas
Log inCreate account

Brian G. Monks

Active 1997–2016

31
Papers
20,032
Citations
31
h-index
31
i10-index

Citations

Citations per year for Brian G. Monks1995: 1 citations1996: 1 citations1998: 3 citations1999: 15 citations2000: 49 citations2001: 105 citations2002: 119 citations2003: 105 citations2004: 188 citations2005: 201 citations2006: 222 citations2007: 210 citations2008: 177 citations2009: 226 citations2010: 248 citations2011: 243 citations2012: 239 citations2013: 292 citations2014: 329 citations2015: 344 citations2016: 339 citations2017: 388 citations2018: 323 citations2019: 903 citations2020: 993 citations2021: 940 citations2022: 857 citations2023: 608 citations2024: 773 citations2025: 446 citations2026: 6 citations1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,198 citing papers, 26.8% of this breakdownChina: 2,265 citing papers, 19% of this breakdownGermany: 769 citing papers, 6.4% of this breakdownUnited Kingdom: 572 citing papers, 4.8% of this breakdownJapan: 487 citing papers, 4.1% of this breakdownAustralia: 376 citing papers, 3.1% of this breakdownCanada: 340 citing papers, 2.8% of this breakdownFrance: 324 citing papers, 2.7% of this breakdownItaly: 283 citing papers, 2.4% of this breakdownSouth Korea: 249 citing papers, 2.1% of this breakdownIndia: 210 citing papers, 1.8% of this breakdownSpain: 203 citing papers, 1.7% of this breakdown
0%26.8%Other 22.3%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology44.7%
  • Immunology and Microbiology28.7%
  • Medicine17.9%
  • Neuroscience5.5%
  • Agricultural and Biological Sciences0.9%
  • Nursing0.5%
  • Other1.8%

Topics

  • Inflammasome and immune disorders14.7%
  • Immune Response and Inflammation8.7%
  • interferon and immune responses5.5%
  • Neuroinflammation and Neurodegeneration Mechanisms2.7%
  • Heme Oxygenase-1 and Carbon Monoxide2.5%
  • Immune Cell Function and Interaction2.1%
  • Other63.8%

Coauthors

All papers

Open in search
  1. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

    Authors: Rebecca C. Coll, Avril A. B. Robertson, Jae Jin Chae, Sarah Higgins, Raúl Muñoz-Planillo, Marco Inserra, Irina Vetter, Lara S. Dungan, Brian G. Monks, Andrea Stutz, Daniel E. Croker, Mark S. Butler, Moritz Haneklaus, Caroline E. Sutton, Gabriel Núñez, Eicke Latz, Daniel L. Kastner, Kingston H. G. Mills, Seth L. Masters, Kate Schroder, Matthew A. Cooper, Luke O'neill - Nature Medicine 2015 cited by 2,784

  2. Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression

    Authors: Franz Bauernfeind, Gábor Horváth, Andrea Stutz, Emad S. Alnemri, Kelly L. MacDonald, David P. Speert, Teresa Fernandes‐Alnemri, Jianghong Wu, Brian G. Monks, Katherine A. Fitzgerald, Veit Hornung, Eicke Latz - The Journal of Immunology 2009 cited by 2,899

  3. The NALP3 inflammasome is involved in the innate immune response to amyloid-β

    Authors: Annett Halle, Veit Hornung, Gabor C. Petzold, Cameron R. Stewart, Brian G. Monks, Thomas Reinheckel, Katherine A. Fitzgerald, Eicke Latz, Kathryn J. Moore, Douglas T. Golenbock - Nature Immunology 2008 cited by 2,403

  4. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses

    Authors: Vijay Rathinam, Zhaozhao Jiang, Stephen N. Waggoner, Shruti Sharma, Leah E. Cole, Lisa Waggoner, Sivapriya Kailasan Vanaja, Brian G. Monks, Sandhya Ganesan, Eicke Latz, Veit Hornung, Stefanie N. Vogel, Eva Szomolanyi‐Tsuda, Katherine A. Fitzgerald - Nature Immunology 2010 cited by 1,300

  5. Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid

    Authors: Joseph Conlon, Dara Burdette, Shruti Sharma, Numana Bhat, Mikayla Thompson, Zhaozhao Jiang, Vijay Rathinam, Brian G. Monks, Tengchuan Jin, Tsan Sam Xiao, Stefanie N. Vogel, Russell E. Vance, Katherine A. Fitzgerald - The Journal of Immunology 2013 cited by 425

  6. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation

    Authors: Bernardo S. Franklin, Lukas Bossaller, Dominic De Nardo, Jacqueline M. Ratter, Andrea Stutz, Gudrun Engels, Christoph Brenker, Mark Nordhoff, Sandra R. Mirandola, Ashraf Al‐Amoudi, Matthew Mangan, Sebastian Zimmer, Brian G. Monks, Martin Fricke, Reinhold E. Schmidt, Terje Espevik, Bernadette Jones, Andrew Jarnicki, Philip M. Hansbro, Patricia Busto, Ann Marshak‐Rothstein, Simone Hornemann, Adriano Aguzzi, Wolfgang Kastenmüller, Eicke Latz - Nature Immunology 2014 cited by 759

  7. LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF

    Authors: Katherine A. Fitzgerald, Daniel C. Rowe, Betsy Barnes, Daniel R. Caffrey, Alberto Visintin, Eicke Latz, Brian G. Monks, Paula M. Pitha, Douglas T. Golenbock - The Journal of Experimental Medicine 2003 cited by 1,194

  8. A Long Noncoding RNA Mediates Both Activation and Repression of Immune Response Genes

    Authors: Susan Carpenter, Daniel Aiello, Maninjay Atianand, Emiliano P. Ricci, Pallavi Gandhi, Lisa L. Hall, Meg Byron, Brian G. Monks, Meabh Henry-Bezy, Jeanne B. Lawrence, Luke O'neill, Melissa J. Moore, Daniel R. Caffrey, Katherine A. Fitzgerald - Science 2013 cited by 972

  9. ASC Speck Formation as a Readout for Inflammasome Activation

    Authors: Andrea Stutz, Gábor Horváth, Brian G. Monks, Eicke Latz - Methods in molecular biology 2013 cited by 340

  10. TLR9 signals after translocating from the ER to CpG DNA in the lysosome

    Authors: Eicke Latz, Annett Schoenemeyer, Alberto Visintin, Katherine A. Fitzgerald, Brian G. Monks, Cathrine Knetter, Egil Lien, Nadra Nilsen, Terje Espevik, Douglas T. Golenbock - Nature Immunology 2004 cited by 1,349

  11. Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation

    Authors: Michael J. Primiano, Bruce A. Lefker, Michael Bowman, Andrea G. Bree, Cédric Hubeau, Paul D. Bonin, Matthew Mangan, Ken Dower, Brian G. Monks, Leah Cushing, Stephen Wang, Julia A. Guzova, Aiping Jiao, Lih‐Ling Lin, Eicke Latz, David Hepworth, J. Perry Hall - The Journal of Immunology 2016 cited by 178

  12. Ligand-induced conformational changes allosterically activate Toll-like receptor 9

    Authors: Eicke Latz, Anjali Verma, Alberto Visintin, Mei Gong, Cherilyn M. Sirois, Dionne C.G. Klein, Brian G. Monks, C. James McKnight, Marc S. Lamphier, W. Paul Duprex, Terje Espevik, Douglas T. Golenbock - Nature Immunology 2007 cited by 454

  13. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction

    Authors: Daniel C. Rowe, Anne F. McGettrick, Eicke Latz, Brian G. Monks, Nicholas J. Gay, Masahiro Yamamoto, Shizuo Akira, Luke O'neill, Katherine A. Fitzgerald, Douglas T. Golenbock - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 282

  14. A Fluorescent Reporter Mouse for Inflammasome Assembly Demonstrates an Important Role for Cell-Bound and Free ASC Specks during In Vivo Infection

    Authors: Te‐Chen Tzeng, Stefan Schattgen, Brian G. Monks, Donghai Wang, Anna Cerny, Eicke Latz, Katherine A. Fitzgerald, Douglas T. Golenbock - Cell Reports 2016 cited by 127

  15. The RNA Helicase Lgp2 Inhibits TLR-Independent Sensing of Viral Replication by Retinoic Acid-Inducible Gene-I

    Authors: Simon Rothenfußer, Nadège Goutagny, Gary DiPerna, Mei Gong, Brian G. Monks, Annett Schoenemeyer, Masahiro Yamamoto, Shizuo Akira, Katherine A. Fitzgerald - The Journal of Immunology 2005 cited by 621

  16. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide

    Authors: Egil Lien, Terry K. Means, Holger Heine, Atsutoshi Yoshimura, Shoichi Kusumoto, Koichi Fukase, Matthew J. Fenton, Masato Oikawa, Nilofer Qureshi, Brian G. Monks, Robert W. Finberg, Robin R. Ingalls, Douglas T. Golenbock - Journal of Clinical Investigation 2000 cited by 737

  17. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9

    Authors: Peggy Parroche, Fanny N. Lauw, Nadège Goutagny, Eicke Latz, Brian G. Monks, Alberto Visintin, Kristen A. Halmen, Marc S. Lamphier, Martin Olivier, Daniella Castanheira Bartholomeu, Ricardo T. Gazzinelli, Douglas T. Golenbock - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 567

  18. Binding of C4b-Binding Protein to Porin

    Authors: Sanjay Ram, Méabh Cullinane, Anna M. Blom, Sunita Gulati, Daniel P. McQuillen, Brian G. Monks, Catherine M. O’Connell, Ryan Boden, Christopher A. Elkins, Michael K. Pangburn, Björn Dahlbäck, Peter A. Rice - The Journal of Experimental Medicine 2001 cited by 221

  19. Lipopolysaccharide Rapidly Traffics to and from the Golgi Apparatus with the Toll-like Receptor 4-MD-2-CD14 Complex in a Process That Is Distinct from the Initiation of Signal Transduction

    Authors: Eicke Latz, Alberto Visintin, Egil Lien, Kate A. Fitzgerald, Brian G. Monks, Evelyn A. Kurt‐Jones, Douglas T. Golenbock, Terje Espevik - Journal of Biological Chemistry 2002 cited by 451

  20. Involvement of Toll-like Receptor (TLR) 2 and TLR4 in Cell Activation by Mannuronic Acid Polymers

    Authors: Trude Helen Flo, Liv Ryan, Eicke Latz, Osamu Takeuchi, Brian G. Monks, Egil Lien, Øyvind Halaas, Shizuo Akira, Gudmund Skjåk‐Bræk, Douglas T. Golenbock, Terje Espevik - Journal of Biological Chemistry 2002 cited by 195

  21. Molecular Genetic Analysis of an Endotoxin Nonresponder Mutant Cell Line

    Authors: Andra B. Schromm, Egil Lien, Philipp Henneke, Jesse C. Chow, Atsutoshi Yoshimura, Holger Heine, Eicke Latz, Brian G. Monks, David A. Schwartz, Kensuke Miyake, Douglas T. Golenbock - The Journal of Experimental Medicine 2001 cited by 306

  22. Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages

    Authors: Kathryn J. Moore, Lorna P. Andersson, Robin R. Ingalls, Brian G. Monks, Rui Li, M. Amin Arnaout, Douglas T. Golenbock, Mason W. Freeman - The Journal of Immunology 2000 cited by 223

  23. Targeted Deletion of the Lipopolysaccharide (LPS)-binding Protein Gene Leads to Profound Suppression of LPS Responses Ex Vivo, whereas In Vivo Responses Remain Intact

    Authors: Mark M. Wurfel, Brian G. Monks, Robin R. Ingalls, Russell L. Dedrick, Russell L. Delude, D Zhou, Norbert Lamping, Ralf R. Schumann, Rolf Thieringer, Matthew J. Fenton, Samuel D. Wright, Douglas T. Golenbock - The Journal of Experimental Medicine 1997 cited by 175

  24. iGLuc: a luciferase-based inflammasome and protease activity reporter

    Authors: Eva Bartok, Franz Bauernfeind, Maria G Khaminets, Christopher Jakobs, Brian G. Monks, Katherine A. Fitzgerald, Eicke Latz, Veit Hornung - Nature Methods 2013 cited by 76